General Probiotics (GP) is a platform company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases.

GP designs, builds and tests advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably.

GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the USDA to pursue an agile R&D program.